Cargando…

Association of COVID-19 with Disability Progression and Disease Exacerbation in People with Relapsing-Remitting Multiple Sclerosis: Evidence from a Year-Long Observational Study

Detalles Bibliográficos
Autores principales: Sedaghat, Nahad, Etemadifar, Masoud, Nouri, Hosein, Abhari, Amir Parsa, Maleki, Shiva, Amin, Alireza, Salari, Mehri
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765397/
http://dx.doi.org/10.1016/j.msard.2022.103589
_version_ 1784853476789977088
author Sedaghat, Nahad
Etemadifar, Masoud
Nouri, Hosein
Abhari, Amir Parsa
Maleki, Shiva
Amin, Alireza
Salari, Mehri
author_facet Sedaghat, Nahad
Etemadifar, Masoud
Nouri, Hosein
Abhari, Amir Parsa
Maleki, Shiva
Amin, Alireza
Salari, Mehri
author_sort Sedaghat, Nahad
collection PubMed
description
format Online
Article
Text
id pubmed-9765397
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-97653972022-12-21 Association of COVID-19 with Disability Progression and Disease Exacerbation in People with Relapsing-Remitting Multiple Sclerosis: Evidence from a Year-Long Observational Study Sedaghat, Nahad Etemadifar, Masoud Nouri, Hosein Abhari, Amir Parsa Maleki, Shiva Amin, Alireza Salari, Mehri Mult Scler Relat Disord Article Published by Elsevier B.V. 2022-03 2022-05-19 /pmc/articles/PMC9765397/ http://dx.doi.org/10.1016/j.msard.2022.103589 Text en Copyright © 2022 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Sedaghat, Nahad
Etemadifar, Masoud
Nouri, Hosein
Abhari, Amir Parsa
Maleki, Shiva
Amin, Alireza
Salari, Mehri
Association of COVID-19 with Disability Progression and Disease Exacerbation in People with Relapsing-Remitting Multiple Sclerosis: Evidence from a Year-Long Observational Study
title Association of COVID-19 with Disability Progression and Disease Exacerbation in People with Relapsing-Remitting Multiple Sclerosis: Evidence from a Year-Long Observational Study
title_full Association of COVID-19 with Disability Progression and Disease Exacerbation in People with Relapsing-Remitting Multiple Sclerosis: Evidence from a Year-Long Observational Study
title_fullStr Association of COVID-19 with Disability Progression and Disease Exacerbation in People with Relapsing-Remitting Multiple Sclerosis: Evidence from a Year-Long Observational Study
title_full_unstemmed Association of COVID-19 with Disability Progression and Disease Exacerbation in People with Relapsing-Remitting Multiple Sclerosis: Evidence from a Year-Long Observational Study
title_short Association of COVID-19 with Disability Progression and Disease Exacerbation in People with Relapsing-Remitting Multiple Sclerosis: Evidence from a Year-Long Observational Study
title_sort association of covid-19 with disability progression and disease exacerbation in people with relapsing-remitting multiple sclerosis: evidence from a year-long observational study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765397/
http://dx.doi.org/10.1016/j.msard.2022.103589
work_keys_str_mv AT sedaghatnahad associationofcovid19withdisabilityprogressionanddiseaseexacerbationinpeoplewithrelapsingremittingmultiplesclerosisevidencefromayearlongobservationalstudy
AT etemadifarmasoud associationofcovid19withdisabilityprogressionanddiseaseexacerbationinpeoplewithrelapsingremittingmultiplesclerosisevidencefromayearlongobservationalstudy
AT nourihosein associationofcovid19withdisabilityprogressionanddiseaseexacerbationinpeoplewithrelapsingremittingmultiplesclerosisevidencefromayearlongobservationalstudy
AT abhariamirparsa associationofcovid19withdisabilityprogressionanddiseaseexacerbationinpeoplewithrelapsingremittingmultiplesclerosisevidencefromayearlongobservationalstudy
AT malekishiva associationofcovid19withdisabilityprogressionanddiseaseexacerbationinpeoplewithrelapsingremittingmultiplesclerosisevidencefromayearlongobservationalstudy
AT aminalireza associationofcovid19withdisabilityprogressionanddiseaseexacerbationinpeoplewithrelapsingremittingmultiplesclerosisevidencefromayearlongobservationalstudy
AT salarimehri associationofcovid19withdisabilityprogressionanddiseaseexacerbationinpeoplewithrelapsingremittingmultiplesclerosisevidencefromayearlongobservationalstudy